ACE — Ascelia Pharma AB Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Annual balance sheet for Ascelia Pharma AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	262	150	21.9	75.3	49.9
Net Total Receivables	5.56	4.53	2.46	5.69	2.77
Prepaid Expenses
Total Other Current Assets
Total Current Assets	275	161	28.9	83.7	53.9
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1.82	0.625	1.06	0.124	0.937
Net Intangible Assets
Other Long Term Assets
Total Assets	333	219	87.1	141	112
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	25.1	37.5	12.6	62	12.4
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	25.7	37.7	12.7	62	12.5
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	308	181	74.3	78.9	99.5
Total Liabilities & Shareholders' Equity	333	219	87.1	141	112
Total Common Shares Outstanding